Severe limb necrosis: primary thrombotic microangiopathy or "seronegative" catastrophic antiphospholipid syndrome? A diagnostic dilemma

被引:13
作者
Lazurova, I.
Macejova, Z.
Tomkova, Z.
Remenar, F.
Boor, A.
Lazur, J.
Roland, R.
Rovensky, J.
Asherson, R. A.
机构
[1] Univ Kosice, Fac Med, Dept Internal Med 1, SK-04011 Kosice, Slovakia
[2] Natl Inst Rheumat Dis, Piestany, Slovakia
[3] Univ Witwatersrand, Sch Pathol, Div Immunol, Johannesburg, South Africa
关键词
cerebral hemorrhage; hyperbaric oxygen; prostacycline; seronegative CAPS; TTP/HUS syndrome;
D O I
10.1007/s10067-006-0487-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An episode of gastroenteritis triggered severe necrosis of all extremities in a previously asymptomatic male. Hepatic and renal involvement were also manifest, while the hematological picture was one of thrombotic microangiopathic hemolytic anemia. Antiphospholipid antibodies were negative. He responded well to a combination of plasma exchange, anticoagulation (heparin), parenteral steroids, and antibiotics, as well as vasodilators (prostacycline) and hyperbaric oxygen, but died because of a cerebral hemorrhage. The differential diagnosis included thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome, or seronegative catastrophic antiphospholipid (Asherson's) syndrome. The dangers of administering such a combination of therapies with anticoagulation, as well as vasodilatation (prostacycline) and hyperbaric oxygen, are highlighted by the case report and emphasized.
引用
收藏
页码:1737 / 1740
页数:4
相关论文
共 22 条
[1]   Anticardiolipin antibodies in classic pediatric hemolytic-uremic syndrome:: A possible pathogenic role [J].
Ardiles, LG ;
Olavarría, F ;
Elgueta, M ;
Moya, P ;
Mezzano, S .
NEPHRON, 1998, 78 (03) :278-283
[2]  
Asherson R.A., 2006, FUTURE RHEUMATOL, V1, P355, DOI [10.2217/17460816.1.3.355, DOI 10.2217/17460816.1.3.355]
[3]   Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome [J].
Asherson, RA .
IMMUNOBIOLOGY, 2005, 210 (10) :727-733
[4]  
ASHERSON RA, 1992, J RHEUMATOL, V19, P508
[5]   Insights into von Willebrand factor proteolysis: clinical implications [J].
Bowen, DJ ;
Collins, PW .
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 (05) :457-467
[6]   SYSTEMIC LUPUS-ERYTHEMATOSUS - CLINICAL AND IMMUNOLOGICAL PATTERNS OF DISEASE EXPRESSION IN A COHORT OF 1,000 PATIENTS [J].
CERVERA, R ;
KHAMASHTA, MA ;
FONT, J ;
SEBASTIANI, GD ;
GIL, A ;
LAVILLA, P ;
DOMENECH, I ;
AYDINTUG, AO ;
JEDRYKAGORAL, A ;
DERAMON, E ;
GALEAZZI, M ;
HAGA, HJ ;
MATHIEU, A ;
HOUSSIAU, F ;
INGELMO, M ;
HUGHES, GRV ;
CERVERA, R ;
SEBASTIANI, GD ;
FONT, J ;
KHAMASHTA, MA ;
HUGHES, GRV ;
FONT, J ;
CERVERA, R ;
LOPEZSOTO, A ;
VIVANCOS, J ;
INGELMO, M ;
URBANOMARQUEZ, A ;
KHAMASHTA, MA ;
VIANNA, J ;
HUGHES, GRV ;
GIL, A ;
LAVILLA, P ;
PINTADO, V ;
LOPEZDUPLA, M ;
VAZQUEZ, JJ ;
SEBASTIANI, GD ;
DERAMON, E ;
CAMPS, M ;
FRUTOS, MA ;
PERELLO, I ;
SANTOS, PG ;
ABARCA, M ;
NEBRO, AF ;
DOMENECH, I ;
TOKGOZ, G ;
AYDINTUG, AO ;
JEDRYKAGORAL, A ;
MALDYKOWA, H ;
CHWALINSKASADOWSKA, H ;
GALEAZZI, M .
MEDICINE, 1993, 72 (02) :113-124
[7]   Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thrombocytopenic purpura [J].
Dang, CT ;
Magid, MS ;
Weksler, B ;
Chadburn, A ;
Laurence, J .
BLOOD, 1999, 93 (04) :1264-1270
[8]   Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies [J].
Espinosa, G ;
Bucciarelli, S ;
Cervera, R ;
Lozano, M ;
Reverter, JC ;
de la Red, G ;
Gil, V ;
Ingelmo, M ;
Font, J ;
Asherson, RA .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (06) :730-736
[9]   Treatment of thrombotic thrombocytopenic purpura [J].
Fontana, S ;
Hovinga, JAK ;
Lämmle, B ;
Taleghani, BM .
VOX SANGUINIS, 2006, 90 (04) :245-254
[10]  
Fujisaki K, 2005, CLIN NEPHROL, V64, P305